Acumen Pharmaceuticals, Inc. (ABOS)
Nasdaq: ABOS · CIK 0001576885 · United States
Every official Acumen Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ABOS filings
Acumen Pharmaceuticals, Inc. documents
- Acumen Pharmaceuticals, Inc. 10-K 2026ABOS 10-K 2026: annual report for fiscal 2026
- Acumen Pharmaceuticals, Inc. 10-K 2025ABOS 10-K 2025: annual report for fiscal 2025
- Acumen Pharmaceuticals, Inc. 10-K 2024ABOS 10-K 2024: annual report for fiscal 2024
- Acumen Pharmaceuticals, Inc. 10-K 2023ABOS 10-K 2023: annual report for fiscal 2023
- Acumen Pharmaceuticals, Inc. 10-K 2022ABOS 10-K 2022: annual report for fiscal 2022
- Acumen Pharmaceuticals, Inc. 10-Q 2026ABOS 10-Q 2026: quarterly report for fiscal 2026
- Acumen Pharmaceuticals, Inc. 10-Q 2025ABOS 10-Q 2025: quarterly report for fiscal 2025
- Acumen Pharmaceuticals, Inc. 10-Q 2024ABOS 10-Q 2024: quarterly report for fiscal 2024
- Acumen Pharmaceuticals, Inc. 10-Q 2023ABOS 10-Q 2023: quarterly report for fiscal 2023
- Acumen Pharmaceuticals, Inc. 10-Q 2022ABOS 10-Q 2022: quarterly report for fiscal 2022
- Acumen Pharmaceuticals, Inc. 8-K 2026ABOS 8-K 2026: current report for fiscal 2026
- Acumen Pharmaceuticals, Inc. 8-K 2025ABOS 8-K 2025: current report for fiscal 2025
- Acumen Pharmaceuticals, Inc. 8-K 2024ABOS 8-K 2024: current report for fiscal 2024
- Acumen Pharmaceuticals, Inc. 8-K 2023ABOS 8-K 2023: current report for fiscal 2023
- Acumen Pharmaceuticals, Inc. 8-K 2022ABOS 8-K 2022: current report for fiscal 2022
- Acumen Pharmaceuticals, Inc. DEF 14A 2026ABOS DEF 14A 2026: proxy statement for fiscal 2026
- Acumen Pharmaceuticals, Inc. DEF 14A 2025ABOS DEF 14A 2025: proxy statement for fiscal 2025
- Acumen Pharmaceuticals, Inc. DEF 14A 2024ABOS DEF 14A 2024: proxy statement for fiscal 2024
- Acumen Pharmaceuticals, Inc. DEF 14A 2023ABOS DEF 14A 2023: proxy statement for fiscal 2023
- Acumen Pharmaceuticals, Inc. DEF 14A 2022ABOS DEF 14A 2022: proxy statement for fiscal 2022
- Acumen Pharmaceuticals, Inc. Form 4 2026ABOS Form 4 2026: insider trading filing for fiscal 2026
- Acumen Pharmaceuticals, Inc. Form 4 2025ABOS Form 4 2025: insider trading filing for fiscal 2025
- Acumen Pharmaceuticals, Inc. Form 4 2024ABOS Form 4 2024: insider trading filing for fiscal 2024
- Acumen Pharmaceuticals, Inc. Form 4 2023ABOS Form 4 2023: insider trading filing for fiscal 2023
- Acumen Pharmaceuticals, Inc. Form 4 2022ABOS Form 4 2022: insider trading filing for fiscal 2022
- Acumen Pharmaceuticals, Inc. S-1 2026ABOS S-1 2026: registration statement for fiscal 2026
- Acumen Pharmaceuticals, Inc. S-1 2025ABOS S-1 2025: registration statement for fiscal 2025
- Acumen Pharmaceuticals, Inc. S-1 2024ABOS S-1 2024: registration statement for fiscal 2024
- Acumen Pharmaceuticals, Inc. S-1 2023ABOS S-1 2023: registration statement for fiscal 2023
- Acumen Pharmaceuticals, Inc. S-1 2022ABOS S-1 2022: registration statement for fiscal 2022
- Acumen Pharmaceuticals, Inc. 13F 2026ABOS 13F 2026: institutional holdings for fiscal 2026
- Acumen Pharmaceuticals, Inc. 13F 2025ABOS 13F 2025: institutional holdings for fiscal 2025
- Acumen Pharmaceuticals, Inc. 13F 2024ABOS 13F 2024: institutional holdings for fiscal 2024
- Acumen Pharmaceuticals, Inc. 13F 2023ABOS 13F 2023: institutional holdings for fiscal 2023
- Acumen Pharmaceuticals, Inc. 13F 2022ABOS 13F 2022: institutional holdings for fiscal 2022
More companies